Artemis DNA™
GENEius Cancer Risk
Profile
$500
Next-generation sequencing (NGS) assay that assesses a person’s increased risk of developing the disease based on their genetic makeup. 102 genes associated with common cancers.
Artemis DNA™
Trucheck Pragma Cancer
Early Detection
$700
Liquid biopsy test that is intended for early detection of Lung, Stomach, Colon, Pancreas, Prostate, Breast and Ovarian cancers.
Artemis DNA™
Cancertrack Cancer Monitor and Manage Recurrence
$1,500
Liquid biopsy test that analyses ctDNA, CTCs and/or exosomes in the course of cancer. Liquid biopsy test that analyses ctDNA, CTCs and/or exosomes in the course of cancer. Recurrences or disease progression can thus be detected as early as possible and therapy can be adjusted.
Artemis DNA™
RemedySelect Cancer Tumor Profile
$3,000
Next-generation sequencing (NGS) assay that enables in-house comprehensive genomic profiling of tumor samples.